This article on Epainassist.com has been reviewed by a medical professional, as well as checked for facts, to assure the readers the best possible accuracy.

We follow a strict editorial policy and we have a zero-tolerance policy regarding any level of plagiarism. Our articles are resourced from reputable online pages. This article may contains scientific references. The numbers in the parentheses (1, 2, 3) are clickable links to peer-reviewed scientific papers.

The feedback link “Was this Article Helpful” on this page can be used to report content that is not accurate, up-to-date or questionable in any manner.

This article does not provide medical advice.


Vasoplegic Syndrome : Causes, Symptoms, and Treatment Options Explained

Vasoplegic syndrome is a complex condition characterized by severe vasodilation and low systemic vascular resistance, leading to inadequate tissue perfusion and organ dysfunction. This article aims to provide a comprehensive understanding of vasoplegic syndrome, including its causes, symptoms, and available treatment options. By delving into the intricacies of this syndrome, we can better grasp its implications and explore potential strategies for management.

What is Vasoplegic Syndrome?

Vasoplegic syndrome refers to a state of systemic vasodilation and vascular hyporesponsiveness. It commonly occurs following cardiac surgery, particularly in patients undergoing cardiopulmonary bypass. However, it can also manifest in other clinical settings, such as septic shock, trauma, or liver transplantation. The underlying pathophysiology involves a dysregulated balance between vasoconstrictor and vasodilator factors, resulting in an inability to maintain adequate blood pressure and tissue perfusion.(1)

Causes of Vasoplegic Syndrome:

Several factors contribute to the development of vasoplegic syndrome. These include:

Inflammatory Response: Activation of the systemic inflammatory response during cardiac surgery or sepsis can trigger vasodilation and impair vascular responsiveness.(2)

  1. Endothelial Dysfunction: Dysfunction of the endothelial lining, often caused by ischemia-reperfusion injury, can disrupt normal vascular tone regulation and contribute to vasoplegia.(2)
  2. Nitric Oxide (NO) Overproduction: Excessive production of nitric oxide, a potent vasodilator, can occur in conditions such as sepsis, leading to vascular hyporesponsiveness.(2)
  3. Genetic Predisposition: Certain genetic polymorphisms have been associated with an increased susceptibility to vasoplegic syndrome.(2)

Symptoms and Clinical Presentation of Vasoplegic Syndrome:

The clinical presentation of vasoplegic syndrome varies depending on the underlying condition and the extent of vascular dysfunction. Common symptoms and signs include:

Hypotension: Persistently low blood pressure despite adequate fluid resuscitation and the use of vasopressor medications.(3)

  1. Tachycardia: Increased heart rate as a compensatory mechanism to maintain cardiac output.
  2. Decreased Organ Perfusion: Signs of inadequate organ perfusion, such as altered mental status, oliguria, cool extremities, and prolonged capillary refill time.
  3. Metabolic Acidosis: Build-up of lactic acid due to tissue hypoperfusion, resulting in metabolic acidosis.

 Diagnosis and Evaluation of Vasoplegic Syndrome:

The diagnosis of vasoplegic syndrome is primarily clinical, based on the presence of persistent hypotension despite adequate fluid resuscitation and the exclusion of other causes. Additional diagnostic measures may include:

  1. Hemodynamic Monitoring: Continuous monitoring of blood pressure, cardiac output, and other relevant hemodynamic parameters to assess the severity of vasoplegia.
  2. Biomarkers: Measurement of biomarkers, such as lactate levels, to evaluate tissue perfusion and the severity of organ dysfunction.
  3. Imaging Studies: Imaging modalities, including echocardiography, can provide valuable insights into cardiac function and rule out other cardiovascular abnormalities.
  1. Treatment Options of Vasoplegic Syndrome:

    The management of vasoplegic syndrome focuses on restoring vascular tone, optimizing tissue perfusion, and treating the underlying cause. Treatment options may include:

    1. Vasopressor Therapy: Administration of vasoconstrictor medications, such as norepinephrine or phenylephrine, to increase systemic vascular resistance and improve blood pressure.(4)
    2. Fluid Resuscitation: Adequate fluid resuscitation is crucial to optimize intravascular volume and improve tissue perfusion. However, caution should be exercised to prevent fluid overload, especially in patients with compromised cardiac function.
    3. Vasopressin Infusion: Vasopressin, a hormone involved in vasoconstriction, may be used as an adjunctive therapy in refractory cases of vasoplegic syndrome.(4)
    4. Methylene Blue: Methylene blue, a medication with vasopressor properties, can be considered in cases of vasoplegia that are unresponsive to conventional therapies. It works by inhibiting nitric oxide synthase and improving vascular tone.(4)
    5. Hydrocortisone: In some instances, administration of corticosteroids, such as hydrocortisone, may help mitigate the inflammatory response and improve vascular reactivity.(4)
    6. Supportive Measures: Supportive care, including adequate oxygenation, maintenance of euvolemia, and optimization of cardiac function, is essential in managing vasoplegic syndrome.
  2. Prevention Strategies of Vasoplegic Syndrome:

    Preventing vasoplegic syndrome is crucial, particularly in high-risk patient populations. Some preventive strategies include:

    1. Preoperative Optimization: Comprehensive preoperative assessment and optimization of patients with known risk factors, including those with a history of cardiac disease or sepsis, may help reduce the incidence of vasoplegic syndrome.
    2. Minimizing Cardiopulmonary Bypass Time: During cardiac surgery, minimizing the duration of cardiopulmonary bypass and the use of aortic cross-clamping can help reduce the inflammatory response and subsequent vasoplegia.
    3. Individualized Management: Tailoring management strategies based on the patient’s specific needs and underlying conditions can improve outcomes and reduce the risk of vasoplegic syndrome. 
  3. Prognosis and Complications of Vasoplegic Syndrome:

    The prognosis of vasoplegic syndrome depends on various factors, including the underlying condition, the promptness of diagnosis, and the effectiveness of treatment. Complications associated with vasoplegic syndrome may include multiorgan dysfunction, prolonged hospitalization, and increased morbidity and mortality rates.


Vasoplegic syndrome presents a significant challenge in various clinical scenarios, necessitating a multidisciplinary approach for optimal management. Understanding the causes, recognizing the symptoms, and implementing appropriate treatment options are crucial for improving patient outcomes. Further research is needed to develop more targeted therapies and preventive strategies to effectively address this complex syndrome.

Remember, if you suspect the presence of vasoplegic syndrome or are experiencing symptoms associated with it, consult a medical professional promptly. They can provide a comprehensive evaluation, accurate diagnosis, and individualized treatment plan based on your specific needs.


  1. Ltaief Z, Ben-Hamouda N, Rancati V, Gunga Z, Marcucci C, Kirsch M, Liaudet L. Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care. Journal of Clinical Medicine. 2022; 11(21):6407. https://www.mdpi.com/2077-0383/11/21/6407
  2. Ltaief Z, Ben-Hamouda N, Rancati V, Gunga Z, Marcucci C, Kirsch M, Liaudet L. Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care. J Clin Med. 2022 Oct 29;11(21):6407. doi: 10.3390/jcm11216407. PMID: 36362635; PMCID: PMC9658078.
  3. https://www.sciencedirect.com/science/article/abs/pii/S0002962915301506
  4. Muhammad R, Dharmadjati BB, Mulia EPB, Rachmi DA. Vasoplegia: Mechanism and Management Following Cardiopulmonary Bypass. Eurasian J Med. 2022 Feb;54(1):92-99. doi: 10.5152/eurasianjmed.2022.20394. PMID: 35307639; PMCID: PMC9634875.
Team PainAssist
Team PainAssist
Written, Edited or Reviewed By: Team PainAssist, Pain Assist Inc. This article does not provide medical advice. See disclaimer
Last Modified On:June 16, 2023

Recent Posts

Related Posts